Side-by-side comparison of AI visibility scores, market position, and capabilities
Rare disease drug discovery using patient-derived organoids and robotics to screen therapeutics matching real genetic mutations; YC and NSF backed with Stanford-validated pediatric heart disease breakthrough.
Rosebud Biosciences is a San Carlos-based drug discovery company that accelerates therapeutic development for rare diseases by screening drug candidates against patient-derived organoids — miniature 3D organ models grown from patients' own cells with matching genetic mutations — using robotic automation and machine learning to identify compounds that correct disease phenotypes at a scale impossible with traditional cell line testing. Founded in 2020 and backed by Y Combinator, NSF, and other investors with $440,000 in revenue, Rosebud has achieved Stanford-validated research breakthroughs published in prestigious scientific journals, including discovering a novel drug target for pediatric heart disease.
Bucket Robotics builds modular autonomous mobile robots for warehouse and industrial environments, designed for rapid deployment without requiring fixed infrastructure or facility modifications.
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse automation systems that require significant facility modifications, fixed conveyors, and multi-month installation projects, Bucket Robotics' AMRs navigate dynamically using onboard sensors and AI, allowing deployment in existing facilities without permanent infrastructure changes.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.